You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 9, 2025

Drug Price Trends for DISULFIRAM


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for DISULFIRAM

Best Wholesale Price for DISULFIRAM

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
DISULFIRAM 250MG TAB Golden State Medical Supply, Inc. 60429-0196-30 30 30.95 1.03167 EACH 2023-06-15 - 2028-06-14 FSS
DISULFIRAM 250MG TAB Golden State Medical Supply, Inc. 60429-0196-30 30 49.24 1.64133 EACH 2023-06-23 - 2028-06-14 FSS
DISULFIRAM 500MG TAB Golden State Medical Supply, Inc. 00054-0357-25 100 418.77 4.18770 EACH 2023-06-15 - 2028-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for Disulfiram

Overview of Disulfiram

Disulfiram, a medication primarily used to treat chronic alcoholism, works by deterring alcohol consumption through unpleasant reactions when alcohol is ingested. It is a crucial tool in comprehensive addiction therapy, helping patients maintain sobriety.

Market Size and Growth Projections

The global disulfiram market was valued at USD 375.19 million in 2023 and is expected to reach USD 392.75 million in 2024. It is projected to grow at a Compound Annual Growth Rate (CAGR) of 4.81% to reach USD 521.63 million by 2030[1][3][5].

Drivers of Market Growth

Several factors are driving the growth of the disulfiram market:

  • Increasing Prevalence of Alcohol Dependency: The rising incidence of alcoholism worldwide is a significant factor contributing to the expansion of disulfiram use[1][3][5].
  • Healthcare Provider Support: Healthcare providers often support the use of disulfiram for patients struggling with alcoholism, particularly when combined with counseling and psychological support[1][3].
  • Rising Awareness and Mental Health Prioritization: Growing awareness of alcohol-related disorders and a societal shift towards mental health prioritization are also boosting market growth[3][5].

Regional Insights

The market dynamics vary across different regions:

  • Americas: The disulfiram market is rapidly expanding in the Americas due to established healthcare infrastructure and awareness regarding alcohol dependency treatments. The availability of disulfiram is supported by insurance coverage and treatment programs[1].
  • South America: In South America, the market is influenced by local healthcare policies and economic conditions, leading to variable access to disulfiram[1].

Distribution Channels

The distribution of disulfiram is primarily through:

  • Hospital Pharmacies: These are key distribution channels, especially in regions with well-established healthcare systems.
  • Online Pharmacies: Online pharmacies are becoming increasingly important, especially for patients who prefer the convenience of online shopping.
  • Retail Pharmacies: Retail pharmacies also play a significant role in the distribution of disulfiram[1][3].

Pricing and Cost Considerations

The cost of disulfiram varies based on the dosage and quantity:

  • 250 mg Oral Tablet: The cost for a supply of 30 tablets is around $45.86, with a per-unit cost of approximately $1.53[2].
  • 500 mg Oral Tablet: For a supply of 30 tablets, the cost is around $100.34, with a per-unit cost of approximately $3.34[2].

Challenges and Limitations

Despite the growth, the disulfiram market faces several challenges:

  • Side Effects: Disulfiram is associated with side effects such as liver toxicity and allergic reactions, which can deter patients[1][3][5].
  • Alternative Therapies: The availability of alternative therapies with different mechanisms of action also poses a challenge to the market[3][5].

Opportunities for Innovation

To overcome the challenges and drive further growth, several opportunities for innovation exist:

  • Advanced Drug Delivery Systems: Research into tailored dosing regimens, implantable forms, and combination therapies could increase compliance and efficacy[3][5].
  • Personalized Treatment Plans: Studying genetic factors influencing drug metabolism could help in personalizing treatment plans[3][5].
  • Expansion into Emerging Markets: Potential expansion in emerging markets where alcohol consumption is significant could open new market segments[3][5].
  • Integration into Digital Health Platforms: Integrating disulfiram into digital health platforms offering telemedicine and remote patient monitoring could enhance its reach and effectiveness[3][5].

Market Players and Competition

The disulfiram market is characterized by moderate competition, primarily driven by generic manufacturers. Key market players include:

  • Abbott Laboratories
  • Alkem Laboratories Ltd.
  • Allergan plc
  • Aspen Pharmacare Holdings Limited
  • Aurobindo Pharma Limited
  • Bausch Health Companies Inc.
  • Bayer AG
  • Cipla Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Eli Lilly and Company
  • Lupin Pharmaceuticals, Inc.
  • Merck KGaA
  • Mylan N.V.
  • Novartis AG
  • Odyssey pharmaceuticals inc
  • Par pharmaceutical inc
  • Pfizer Inc.
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Watson laboratories Inc.
  • Zydus Lifesciences Limited[3][5].

Potential New Market Segments

Exploring disulfiram's potential in treating other conditions, such as certain cancers where it has shown promise in preliminary studies, could open new market segments and further expand the market[3][5].

Key Takeaways

  • The disulfiram market is projected to grow significantly, driven by increasing awareness of alcohol-related disorders and a societal shift towards mental health.
  • The market faces challenges such as side effects and the availability of alternative therapies.
  • Opportunities for innovation include advanced drug delivery systems, personalized treatment plans, and expansion into emerging markets.
  • The market is moderately competitive, with key players focusing on R&D to improve formulation and delivery methods.

FAQs

What is the primary use of disulfiram?

Disulfiram is primarily used to treat chronic alcoholism by deterring alcohol consumption through unpleasant reactions when alcohol is ingested.

What is the projected market size of disulfiram by 2030?

The disulfiram market is projected to reach USD 521.63 million by 2030, growing at a CAGR of 4.81% from 2023[1][3][5].

What are the main distribution channels for disulfiram?

The main distribution channels for disulfiram include hospital pharmacies, online pharmacies, and retail pharmacies[1][3].

What are some of the side effects associated with disulfiram?

Disulfiram is associated with side effects such as liver toxicity and allergic reactions[1][3][5].

How can the disulfiram market be expanded further?

The market can be expanded further through innovations such as advanced drug delivery systems, personalized treatment plans, and integration into digital health platforms[3][5].

Sources

  1. GlobeNewswire: "Disulfiram Presents a $521+ Million Industry Opportunity by 2030: Increasing Patient Awareness and Higher Treatment Seeking Rate" - June 21, 2024.
  2. Drugs.com: "Disulfiram Prices, Coupons, Copay Cards & Patient Assistance".
  3. GII Research: "Disulfiram Market by Indication (Alcoholism Treatment, Co-occurring Disorders)" - December 1, 2024.
  4. Market Research Intellect: "Global Disulfiram Market Size, Scope And Forecast Report" - December 2024.
  5. GII Research: "Disulfiram Market by Indication, Distribution Channel" - June 5, 2024.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.